TrialBMC infectious diseases2017

Efficacy and safety of de-escalation therapy to ertapenem for treatment of infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: an open-label randomized controlled trial.

Pinyo Rattanaumpawan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.